Top 8 AI Workflow Automation Agencies for Medical Practices (2025)

Tempus is a healthcare technology company focused on advancing precision medicine through the use of artificial intelligence. By processing vast amounts of clinical and molecular data, Tempus supports physicians in making real-time, data-driven decisions for personalized patient care. Its platform combines analytics, machine learning, and diagnostic assays to provide insights that help identify targeted therapies, predict treatment responses, and connect patients to relevant clinical trials across a range of diseases. Tempus focuses on data integration tools, algorithmic models, and AI-enabled assistants that help address gaps in care and inform clinical research. With a mission to continuously improve patient outcomes by leveraging data intelligence, Tempus works to make individualized medicine more accessible and actionable. The company's solutions include data integration tools, algorithmic models, and AI-enabled assistants that help close gaps in care and inform clinical research. Tempus operates within the broader healthtech industry, providing AI-powered solutions for precision medicine and clinical trial support.

Aidoc develops AI-powered solutions for medical imaging to support real-time clinical decision-making. Its FDA and CE-approved algorithms assist in identifying critical conditions such as stroke, pulmonary embolism, and intracranial hemorrhage from CT scans. By automating triage and flagging urgent findings, Aidoc helps radiologists and care teams prioritize high-risk cases more efficiently. The company's platform, built on its proprietary aiOS operating system, is designed to integrate across healthcare systems and clinical workflows. Aidoc provides an enterprise-level solution that aggregates and analyzes imaging data to support coordinated, timely interventions. Its goal is to reduce silos in care delivery while enabling faster, more informed decisions across specialties. Aidoc serves healthcare providers, focusing on radiology and emergency care settings.

PathAI develops artificial intelligence solutions for digital pathology, with a focus on improving the accuracy of disease diagnosis and advancing drug development. Its models are trained on large-scale, expertly annotated datasets to support the analysis of tissue samples, enabling pathologists to detect disease markers more precisely. With a dedication to improving patient outcomes with AI-powered pathology, PathAI's technology is used in both clinical and research settings, particularly in oncology, to aid in diagnostics, biomarker discovery, and clinical trial support. In addition to its diagnostic tools, PathAI partners with pharmaceutical companies and pathology labs to improve laboratory workflows and accelerate therapeutic development. The company's platform combines computational expertise with medical insight to support more efficient and confident clinical decision-making, streamlining analysis and helping bring effective treatments to patients more quickly. PathAI serves pharmaceutical and biotechnology firms, academic medical centers, and pathology labs.

Nuance develops AI-powered ambient documentation tools to reduce administrative workload in healthcare settings. Its platform captures natural clinician-patient conversations and converts them into structured medical notes, data entries, and point-of-care notifications. The goal is to streamline clinical workflows and support decision-making without disrupting the interaction between provider and patient. Used across hospitals and health systems, Nuance's tools are designed to improve operational efficiency and reduce burnout by automating documentation tasks. With data drawn from millions of clinical interactions, the company's solutions integrate into a variety of care environments and are supported by nearly half a million clinicians. Through its technology, Nuance aims to help restore time and focus on patient care. Nuance serves hospitals and health systems with a focus on clinical documentation.

Viz.ai is a medical technology company specializing in AI-powered imaging solutions for vascular and neurovascular conditions. Its platform assists physicians in identifying strokes, aneurysms, pulmonary embolisms, and other critical conditions. The software analyzes CT and MRI scans in real time to support faster diagnosis and treatment decisions across emergency and inpatient settings. With more than 14 million scans processed globally, Viz.ai's platform has been validated through numerous multicenter clinical trials and is integrated into care workflows at over 2,000 hospitals. Its tools span a growing range of use cases, including triage, perfusion imaging, and treatment planning. By combining AI with decades of clinical research, Viz.ai improves care coordination and patient outcomes in time-sensitive, high-acuity scenarios. Viz.ai serves hospitals focusing on emergency and inpatient care.

Butterfly Network is a digital health company transforming care with portable ultrasound technology. Founded in 2011, the company provides over 60,000 in-home patient appointments daily through a network of carers and nurses, offering services that include nursing, telehealth, and medication management. Its platform is designed to shift healthcare delivery out of hospitals and into the home, serving a population of more than 30 million people on behalf of governments, insurers, and national health systems. Butterfly Network's model is 'AI Care'—a system that pairs human clinicians with AI-driven guidance to scale care delivery and enhance patient outcomes. The platform is used to treat a wide range of conditions, from chronic pain to postpartum recovery, and includes support for movement therapy, clinical coordination, and long-term prevention. With a focus on accessibility and outcomes, Butterfly Network aims to make world-class care available to patients regardless of location or background. Butterfly Network serves government health systems, insurers, and home healthcare providers.

Freenome is a biotechnology company advancing early cancer detection through the use of artificial intelligence. By processing vast amounts of clinical and molecular data, Freenome supports physicians in making real-time, data-driven decisions for personalized patient care. Its platform combines analytics, machine learning, and diagnostic assays to provide insights that help identify targeted therapies, predict treatment responses, and connect patients to relevant clinical trials across a range of diseases. Freenome works with research institutions and life sciences partners to accelerate therapeutic discovery and development. The company's solutions include data integration tools, algorithmic models, and AI-enabled assistants that help close gaps in care and inform clinical research. With a mission to continuously improve patient outcomes by leveraging data intelligence, Freenome is working to make individualized medicine more accessible and actionable. Freenome serves research institutions and life sciences partners in oncology and precision medicine.